Table of Contents
<< Previous Issue | Mar 2010 (Vol: 2010, Issue: 3) | Next Issue >> |
- Section: Licensing
-
Astellas Partnership Offsets Ceftobiprole Setback for Basilea
-
Novartis in Novel Therapeutic Cancer Vaccine Deal with Transgene
-
AstraZeneca Follows Other Big Pharma in Forging Emerging Markets Alliances
- Section: Mergers & Acquisitions
-
Merck Acquires Millipore to Advance its Life Sciences Business
-
Abbott Buys Facet Biotech to Enhance Pipeline
-
Astellas Aims for Global Oncology Position through OSI
-
Ratiopharm Acquisition Catapults Teva to Lead European Generics Market